Autism Spectrum Disorder Trial, Recruiting (NCT07021274)

Autism Spectrum Disorder Trial, Recruiting NCT07021274 Sponsor: Helse Møre og Romsdal HF Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07021274 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who meet the general requirements for outpatient treatment at the clinic
People who have been diagnosed with autism and have ongoing difficulties managing their emotions
People who speak a Scandinavian language (Norwegian, Danish, and/or Swedish)
People who are able to commit to attending and participating in a DBT skills training program (a type of structured therapy program)
People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

People whose language or communication abilities are significantly limited in a way that would make it difficult to understand and complete self-report questionnaires
People who are currently experiencing active psychosis (a state involving a loss of contact with reality, such as hallucinations or delusions)
People with a Body Mass Index (BMI) below 17, which is a measure of body weight relative to height
People with a cognitive (intellectual) disability, specifically an IQ score below 85

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Egil Jonsbu, MD, PhD, More And Romsdal Hospital Trust

Phone: +4746746154

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07021274

Sponsor: Helse Møre og Romsdal HF

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +4746746154

More information: https://clinicaltrials.gov/study/NCT07021274

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who meet the general requirements for outpatient treatment at the clinic
People who have been diagnosed with autism and have ongoing difficulties managing their emotions
People who speak a Scandinavian language (Norwegian, Danish, and/or Swedish)
People who are able to commit to attending and participating in a DBT skills training program (a type of structured therapy program)
People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

People whose language or communication abilities are significantly limited in a way that would make it difficult to understand and complete self-report questionnaires
People who are currently experiencing active psychosis (a state involving a loss of contact with reality, such as hallucinations or delusions)
People with a Body Mass Index (BMI) below 17, which is a measure of body weight relative to height
People with a cognitive (intellectual) disability, specifically an IQ score below 85

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Helse Møre og Romsdal HF

Registry

ClinicalTrials.gov

Start date

15 August 2025

Est. completion

28 February 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Difficulties in emotion regulation scale (DERS) - 8; participation in treatment; Dialectical Behavior Therapy- Ways of Coping Checklist (DBT-WCCL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov